HCA Healthcare, Inc. (NYSE:HCA) Stock Holdings Increased by Cwm LLC

CWM LLC boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 18.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,395 shares of the company's stock after buying an additional 1,931 shares during the quarter. CWM LLC's holdings in HCA Healthcare were worth $4,283,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of HCA. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at about $1,021,000. Proficio Capital Partners LLC increased its position in shares of HCA Healthcare by 45.5% in the fourth quarter. Proficio Capital Partners LLC now owns 745 shares of the company's stock worth $223,000 after acquiring an additional 233 shares in the last quarter. Envestnet Portfolio Solutions Inc. increased its position in shares of HCA Healthcare by 14.7% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,623 shares of the company's stock worth $4,689,000 after acquiring an additional 2,002 shares in the last quarter. Corient Private Wealth LLC increased its position in shares of HCA Healthcare by 1.0% in the fourth quarter. Corient Private Wealth LLC now owns 39,067 shares of the company's stock worth $11,724,000 after acquiring an additional 381 shares in the last quarter. Finally, Cibc World Markets Corp increased its position in shares of HCA Healthcare by 13.1% in the fourth quarter. Cibc World Markets Corp now owns 29,268 shares of the company's stock worth $8,785,000 after acquiring an additional 3,383 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA traded down $1.69 during midday trading on Friday, hitting $360.91. The company's stock had a trading volume of 1,029,846 shares, compared to its average volume of 1,452,577. The firm has a market cap of $86.82 billion, a P/E ratio of 16.05, a P/E/G ratio of 1.25 and a beta of 1.47. The firm's fifty day moving average price is $376.24 and its 200-day moving average price is $343.58. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the business posted $5.36 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were given a dividend of $0.72 per share. The ex-dividend date was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.80%. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on HCA. Truist Financial raised their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday. Guggenheim began coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating for the company. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their price target for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Finally, Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Eight research analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $399.21.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.